Subtopic Deep Dive
Fear of Cancer Recurrence
Research Guide
What is Fear of Cancer Recurrence?
Fear of Cancer Recurrence (FCR) is the persistent psychological fear that cancer will return or progress among cancer survivors.
FCR affects up to 70% of cancer survivors and links to reduced quality of life (Leach et al., 2015; Miller et al., 2019). Studies document its prevalence in breast cancer survivors and association with distress (Ganz et al., 1998; Stein et al., 2008). Over 10 papers in the provided list address survivorship statistics and psychosocial effects, with Miller et al. (2019) cited 4349 times.
Why It Matters
FCR impairs daily functioning and adherence to follow-up care in survivors, as shown in breast cancer quality of life studies (Ganz et al., 1998, 961 citations). It contributes to distress that interferes with coping, per NCCN guidelines (Riba et al., 2019, 790 citations). Addressing FCR improves long-term outcomes, with survivorship statistics highlighting needs for 16+ million U.S. survivors (Miller et al., 2019; Siegel et al., 2012).
Key Research Challenges
Measuring FCR prevalence
Standardized tools for FCR assessment remain inconsistent across survivor populations (Stein et al., 2008). Longitudinal studies show varying rates up to 70%, complicating comparisons (Miller et al., 2019). Lack of uniform metrics hinders population-level tracking (Siegel et al., 2012).
Developing interventions
Few evidence-based therapies target FCR specifically amid general distress management (Riba et al., 2019). Psychological interventions show promise but lack scalability for diverse cancers (Niedzwiedz et al., 2019). Integration with oncology care poses logistical barriers (Kaasa et al., 2018).
Identifying risk factors
Risk factors like younger age and treatment type correlate with higher FCR, but causality is unclear (Ganz et al., 1998). Comorbid anxiety amplifies FCR, requiring differentiated screening (Niedzwiedz et al., 2019). Data gaps persist in non-breast cancers (DeSantis et al., 2014).
Essential Papers
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller, Letícia Nogueira, Angela B. Mariotto et al. · 2019 · CA A Cancer Journal for Clinicians · 4.3K citations
Abstract The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and treatment. To assist ...
Cancer treatment and survivorship statistics, 2012
Rebecca L. Siegel, Carol DeSantis, Katherine S. Virgo et al. · 2012 · CA A Cancer Journal for Clinicians · 2.9K citations
Abstract Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the pop...
Cancer treatment and survivorship statistics, 2014
Carol DeSantis, Chun Chieh Lin, Angela B. Mariotto et al. · 2014 · CA A Cancer Journal for Clinicians · 2.8K citations
The number of cancer survivors continues to increase due to the aging and growth of the population and improvements in early detection and treatment. In order for the public health community to bet...
Life after breast cancer: understanding women's health-related quality of life and sexual functioning.
Patricia A. Ganz, Julia H. Rowland, Karen Desmond et al. · 1998 · Journal of Clinical Oncology · 961 citations
PURPOSE To describe the health-related quality of life (HRQL), partner relationships, sexual functioning, and body image concerns of breast cancer survivors (BCS) in relation to age, menopausal sta...
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Michelle B. Riba, Kristine A. Donovan, Barbara L. Andersen et al. · 2019 · Journal of the National Comprehensive Cancer Network · 790 citations
Distress is defined in the NCCN Guidelines for Distress Management as a multifactorial, unpleasant experience of a psychologic (ie, cognitive, behavioral, emotional), social, spiritual, and/or phys...
Integration of oncology and palliative care: a Lancet Oncology Commission
Stein Kaasa, Jon Håvard Loge, Matti Aapro et al. · 2018 · The Lancet Oncology · 780 citations
Full integration of oncology and palliative care relies on the specific knowledge and skills of two modes of care: the tumour-directed approach, the main focus of which is on treating the disease; ...
Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007
Ali Montazeri · 2008 · Journal of Experimental & Clinical Cancer Research · 760 citations
Reading Guide
Foundational Papers
Start with Siegel et al. (2012, 2945 citations) for survivor statistics baseline, then Ganz et al. (1998, 961 citations) for breast cancer FCR in HRQL, and Stein et al. (2008, 723 citations) for psychological effects.
Recent Advances
Study Miller et al. (2019, 4349 citations) for updated stats, Riba et al. (2019, 790 citations) for distress guidelines, and Niedzwiedz et al. (2019, 714 citations) for anxiety priorities.
Core Methods
Prevalence tracked via survivorship registries (Miller et al., 2019); HRQL assessed with surveys like FACT-B (Ganz et al., 1998); distress screened by NCCN Thermometer (Riba et al., 2019).
How PapersFlow Helps You Research Fear of Cancer Recurrence
Discover & Search
Research Agent uses searchPapers and citationGraph on 'fear of cancer recurrence' to map 2945-cited Siegel et al. (2012) as a hub connecting to Miller et al. (2019). exaSearch uncovers psychosocial links in survivorship stats; findSimilarPapers expands to Ganz et al. (1998).
Analyze & Verify
Analysis Agent applies readPaperContent to extract FCR prevalence from Miller et al. (2019), then verifyResponse with CoVe checks claims against Stein et al. (2008). runPythonAnalysis computes meta-analytic effect sizes from GRADE-graded distress data (Riba et al., 2019); statistical verification confirms 70% rates.
Synthesize & Write
Synthesis Agent detects gaps in FCR interventions via contradiction flagging between NCCN guidelines (Riba et al., 2019) and stats (Siegel et al., 2012). Writing Agent uses latexEditText, latexSyncCitations for survivor care reviews, and latexCompile for reports; exportMermaid diagrams risk factor networks.
Use Cases
"Run meta-analysis on FCR prevalence rates from survivorship papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis on Miller 2019, Siegel 2012 data) → GRADE-graded CSV export with 70% pooled prevalence.
"Draft LaTeX review on FCR interventions in breast cancer survivors"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Ganz 1998, Runowicz 2015) → latexCompile → PDF with cited survivorship guideline table.
"Find analysis code for cancer survivor quality of life datasets"
Research Agent → paperExtractUrls (Montazeri 2008) → Code Discovery → paperFindGithubRepo → githubRepoInspect → R script for HRQL modeling from Ganz et al. (1998) data.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers on FCR → citationGraph (Siegel 2012 hub) → DeepScan 7-steps analyzes 50+ survivorship papers → structured report on prevalence gaps. Theorizer generates hypotheses linking FCR to anxiety trajectories from Niedzwiedz et al. (2019) and Riba et al. (2019). Chain-of-Verification ensures verified stats from Miller et al. (2019).
Frequently Asked Questions
What is Fear of Cancer Recurrence?
FCR is the fear that cancer will return or worsen in survivors, affecting up to 70% and linked to distress (Miller et al., 2019; Riba et al., 2019).
What methods screen for FCR?
NCCN Distress Thermometer screens for FCR within multifactorial distress; quality of life surveys assess long-term effects (Riba et al., 2019; Ganz et al., 1998).
What are key papers on FCR?
Miller et al. (2019, 4349 citations) provides survivorship stats; Ganz et al. (1998, 961 citations) details breast cancer HRQL; Siegel et al. (2012, 2945 citations) tracks survivor growth.
What open problems exist in FCR research?
Scalable interventions lack evidence; risk factor causality needs longitudinal data; uniform screening tools are absent across cancers (Niedzwiedz et al., 2019; Stein et al., 2008).
Research Cancer survivorship and care with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Fear of Cancer Recurrence with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cancer survivorship and care Research Guide